Search research articles
Contact Us
Filters
Showing results (101-110 of 145) with videos related to
Page
of 15
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1997
Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody
M Juweid, R M Sharkey, A Alavi, et al.
Journal of Immunological Methods
|
August 6, 1998
Carbohydrates engineered at antibody constant domains can be used for site-specific conjugation of drugs and chelates
Z Qu, R M Sharkey, H J Hansen, et al.
European Journal of Nuclear Medicine
|
January 1, 1992
Lymphoma imaging with a new technetium-99m labelled antibody, LL2
S Murthy, R M Sharkey, D M Goldenberg, et al.
International Journal of Cancer
|
July 29, 1997
Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma
R M Sharkey, R D Blumenthal, T M Behr, et al.
International Journal of Cancer
|
July 15, 1990
Selection of a DTPA chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude mice
R M Sharkey, C Motta-Hennessy, O A Gansow, et al.
Bioconjugate Chemistry
|
July 1, 1997
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model
R M Sharkey, H Karacay, G L Griffiths, et al.
Cancer
|
May 1, 1999
Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma
M E Juweid, G Hajjar, L C Swayne, et al.
Cancer Research
|
November 1, 1992
Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies
R D Blumenthal, R M Sharkey, L Haywood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 1997
Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies
T M Behr, R M Sharkey, M E Juweid, et al.
Cancer Research
|
February 1, 1990
Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens
R M Sharkey, D V Gold, R Aninipot, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 145) with videos related to
Sort By:
Page
of 15
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1997
Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody
M Juweid, R M Sharkey, A Alavi, et al.
Journal of Immunological Methods
|
August 6, 1998
Carbohydrates engineered at antibody constant domains can be used for site-specific conjugation of drugs and chelates
Z Qu, R M Sharkey, H J Hansen, et al.
European Journal of Nuclear Medicine
|
January 1, 1992
Lymphoma imaging with a new technetium-99m labelled antibody, LL2
S Murthy, R M Sharkey, D M Goldenberg, et al.
International Journal of Cancer
|
July 29, 1997
Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma
R M Sharkey, R D Blumenthal, T M Behr, et al.
International Journal of Cancer
|
July 15, 1990
Selection of a DTPA chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude mice
R M Sharkey, C Motta-Hennessy, O A Gansow, et al.
Bioconjugate Chemistry
|
July 1, 1997
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model
R M Sharkey, H Karacay, G L Griffiths, et al.
Cancer
|
May 1, 1999
Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma
M E Juweid, G Hajjar, L C Swayne, et al.
Cancer Research
|
November 1, 1992
Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies
R D Blumenthal, R M Sharkey, L Haywood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 1997
Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies
T M Behr, R M Sharkey, M E Juweid, et al.
Cancer Research
|
February 1, 1990
Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens
R M Sharkey, D V Gold, R Aninipot, et al.
Page
of 15